Detecting kidney DNA to spot organ rejection early
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have at least one working kidney transplant.
- You are scheduled for a kidney biopsy because of a possible problem.
- You are being seen at Pitié Salpêtrière or Necker Hospital.
- You have health insurance through the French social security system (not AME).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (called cfDNA) that may help doctors detect early signs of kidney transplant rejection before problems develop. The goal is to help keep your transplanted kidney healthy longer by catching issues early.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
This study looks at the genes in kidney biopsy tissue from children and young adults who have had a kidney transplant. Researchers want to find genetic markers that could help detect transplant rejection earlier, which might help doctors tailor treatment.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.